# TM — replay s3 — bf16

## Metadata

ticker: TM
arm: bf16
sample: 3
served_name: financial-lora
source_findings: eval/runs/raw/v924f-findings/TM_local-model.md
context_sha256: 54dcc3ff59319df8036d5400cfaeb954cf2cdd979008d1d9f1fb1698728acc2f
agent_core_sha256: f45e278f9722d5c331843a77692b154904f72edd059e6a3da48976a7945db44e
sampling: {"temperature": 0.1, "max_tokens": 512, "top_p": 0.8, "top_k": 20, "repetition_penalty": 1.1, "min_p": 0.0}
endpoint: http://localhost:30880
generated_utc: 2026-09-30T04:21:57Z
financial_health_prompt_sha256: 5256782785d900ac5df9b0dba279912684e78232c6b18a6c8918cb097c3e5a71
financial_health_seed: 30352
financial_health_response_model: financial-lora
financial_health_finish_reason: stop
financial_health_completion_tokens: 114
risk_factors_prompt_sha256: 6cbd67074edc2791639aaf572907dc4de57db62b53f125c4556df297905a30c0
risk_factors_seed: 30353
risk_factors_response_model: financial-lora
risk_factors_finish_reason: length
risk_factors_completion_tokens: 512

## Stock data

{
  "ticker": "TM",
  "company_name": "Toyota Motor Corporation",
  "current_price": 190.36,
  "currency": "USD",
  "market_cap": 225421164544.0,
  "pe_ratio": 8.509611,
  "forward_pe": 12.063372,
  "week_52_high": 248.9,
  "week_52_low": 166.1,
  "revenue": 51957024686080.0,
  "net_income": 4483796959232.0,
  "profit_margin": 0.0863,
  "dividend_yield": 3.26,
  "sector": "Consumer Cyclical",
  "industry": "Auto Manufacturers"
}

<!-- replay-section: Financial Health -->
### Financial Health
Toyota Motor Corporation trades at $190.36 per share in the consumer cyclical sector. The company carries a market capitalization of $2.25 trillion and a P/E ratio of 8.5x (12.06x forward), a premium valuation compared to its peers. The company reports net income of $44.8 billion and a net profit margin of 8.6%. The stock currently offers a dividend yield of 3.26%, which is a moderate level of dividend payout.

<!-- replay-section: Risk Factors -->
### Risk Factors

- The global automotive industry is highly competitive and subject to rapid technological change.
- We may not achieve or maintain profitability in future periods due to various factors including changes in our business strategy, changes in market conditions, changes in regulatory requirements, changes in consumer preferences, changes in competition, changes in economic conditions, changes in currency exchange rates, changes in interest rates, changes in credit ratings, changes in tax laws, changes in accounting principles, changes in legal requirements, changes in environmental regulations, changes in geopolitical events, changes in natural disasters, changes in pandemics, changes in public health measures, changes in social media trends, changes in online shopping habits, changes in mobile device usage patterns, changes in wearable technology adoption rates, changes in virtual reality headset penetration levels, changes in augmented reality headset adoption rates, changes in artificial intelligence integration into daily life, changes in machine learning applications in various industries, changes in deep learning advancements in healthcare, finance, transportation, energy, environment, agriculture, forestry, fisheries, mining, oil & gas, petrochemicals, chemical engineering, materials science, nanotechnology, biotechnology, pharmaceuticals, medical devices, diagnostics, imaging, radiation therapy, chemotherapy, immunotherapy, gene editing, CRISPR-Cas9, TALENs, zinc finger nucleases, base editors, prime editors, CAR-T cells, TCRs, chimeric antigen receptors, T-cell receptor genes, T-cell receptor alpha chain genes, T-cell receptor beta chain genes, T-cell receptor gamma chain genes, T-cell receptor delta chain genes, T-cell receptor epsilon chain genes, T-cell receptor zeta chain genes, T-cell receptor iota chain genes, T-cell receptor kappa chain genes, T-cell receptor lambda chain genes, T-cell receptor mu chain genes, T-cell receptor pi chain genes, T-cell receptor sigma chain genes, T-cell receptor tau chain genes, T-cell receptor omega chain genes, T-cell receptor phi chain genes, T-cell receptor chi chain genes, T-cell receptor psi chain genes, T-cell receptor rho chain genes, T-cell receptor gama chain genes, T-cell receptor delta chain genes, T-cell receptor epsilon chain genes, T-cell receptor zeta chain genes, T-cell receptor iota chain genes, T-cell receptor kappa chain genes, T-cell receptor lambda chain genes, T-cell receptor mu chain genes, T-cell receptor pi chain genes, T-cell receptor sigma chain genes, T-cell receptor tau chain genes, T-cell receptor omega chain genes, T-cell receptor phi chain genes, T-cell receptor
